{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:28:48Z","timestamp":1786120128987,"version":"build-2736575974"},"reference-count":192,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.apsb.2026.06.035","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:24:07Z","timestamp":1782109447000},"page":"5016-5033","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rationale of renewed efforts in developing MC4R modulators to treat metabolic disorders"],"prefix":"10.1016","volume":"16","author":[{"given":"Wenbo","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingtong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6550-9017","authenticated-orcid":false,"given":"Ming-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.06.035_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103363","article-title":"The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions","volume":"86","author":"Moiz","year":"2025","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.apsb.2026.06.035_bib2","article-title":"Comparative efficacy and safety of GLP-1 receptor agonists for weight reduction: a model-based meta-analysis of placebo-controlled trials","volume":"13","author":"Guo","year":"2025","journal-title":"Obes Pillars"},{"key":"10.1016\/j.apsb.2026.06.035_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1146\/annurev-pharmtox-061324-011832","article-title":"Weight loss blockbuster development: a role for unimolecular polypharmacology","volume":"65","author":"Zhou","year":"2025","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.035_bib4","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tips.2025.03.003","article-title":"Structural pharmacology and mechanisms of GLP-1R signaling","volume":"46","author":"Zhou","year":"2025","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.06.035_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/s41392-024-01931-z","article-title":"Glucagon-like peptide-1 receptor: mechanisms and advances in therapy","volume":"9","author":"Zheng","year":"2024","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.apsb.2026.06.035_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13929","article-title":"Discontinuing glucagon-like peptide-1 receptor agonists and body habitus: a systematic review and meta-analysis","volume":"26","author":"Berg","year":"2025","journal-title":"Obes Rev"},{"key":"10.1016\/j.apsb.2026.06.035_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib8","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1111\/dom.16275","article-title":"Body composition changes during weight reduction with tirzepatide in the SURMOUNT-1 study of adults with obesity or overweight","volume":"27","author":"Look","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib9","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/dom.14618","article-title":"Melanocortin-4 receptor complexity in energy homeostasis, obesity and drug development strategies","volume":"24","author":"Fatima","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101206","article-title":"The melanocortin pathway and energy homeostasis: from discovery to obesity therapy","volume":"48","author":"Yeo","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib11","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1016\/j.bbadis.2017.04.010","article-title":"Biased signaling at neural melanocortin receptors in regulation of energy homeostasis","volume":"1863","author":"Yang","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2026.06.035_bib12","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nn.4202","article-title":"Melanocortin-4 receptor-regulated energy homeostasis","volume":"19","author":"Krashes","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.apsb.2026.06.035_bib13","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cmet.2011.01.010","article-title":"Melanocortin-4 receptors expressed by cholinergic neurons regulate energy balance and glucose homeostasis","volume":"13","author":"Rossi","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib14","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1016\/j.bbadis.2017.03.003","article-title":"Role of the brain melanocortins in blood pressure regulation","volume":"1863","author":"Do Carmo","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2026.06.035_bib15","doi-asserted-by":"crossref","first-page":"E468","DOI":"10.1152\/ajpendo.00434.2002","article-title":"The melanocortin system","volume":"284","author":"Gantz","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib16","doi-asserted-by":"crossref","first-page":"8727","DOI":"10.3390\/ijms23158727","article-title":"Melanocortin-5 receptor: pharmacology and its regulation of energy metabolism","volume":"23","author":"Ji","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.035_bib17","doi-asserted-by":"crossref","first-page":"683","DOI":"10.3389\/fendo.2019.00683","article-title":"Melanocortin regulation of inflammation","volume":"10","author":"Wang","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.035_bib18","doi-asserted-by":"crossref","first-page":"8856","DOI":"10.1073\/pnas.90.19.8856","article-title":"Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system","volume":"90","author":"Roselli-Rehfuss","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.06.035_bib19","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1093\/hmg\/ddg016","article-title":"Intracellular retention is a common characteristic of childhood obesity-associated MC4R mutations","volume":"12","author":"Lubrano-Berthelier","year":"2003","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.apsb.2026.06.035_bib20","doi-asserted-by":"crossref","first-page":"e1249","DOI":"10.1210\/clinem\/dgad602","article-title":"Novel melanocortin-3 and -4 receptor functional variants in Asian children with severe obesity","volume":"109","author":"Ong","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib21","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(00)81865-6","article-title":"Targeted disruption of the melanocortin-4 receptor results in obesity in mice","volume":"88","author":"Huszar","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.035_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.molmed.2018.12.002","article-title":"Melanocortin-4 receptor signalling: importance for weight regulation and obesity treatment","volume":"25","author":"K\u00fchnen","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib23","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.cell.2019.03.044","article-title":"Human gain-of-function MC4R variants show signaling bias and protect against obesity","volume":"177","author":"Lotta","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.035_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101077","article-title":"Mouse models for V103I and I251L gain of function variants of the human MC4R display decreased adiposity but are not protected against a hypercaloric diet","volume":"42","author":"Rojo","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib25","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1016\/j.bbadis.2017.08.001","article-title":"Melanocortin receptors","volume":"1863","author":"Tao","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2026.06.035_bib26","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/edrv-9-1-159","article-title":"Proopiomelanocortin processing in the pituitary, central nervous system, and peripheral tissues","volume":"9","author":"Smith","year":"1988","journal-title":"Endocr Rev"},{"key":"10.1016\/j.apsb.2026.06.035_bib27","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/s12276-021-00625-8","article-title":"Developmental programming of hypothalamic melanocortin circuits","volume":"54","author":"Bouret","year":"2022","journal-title":"Exp Mol Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s42255-024-00987-z","article-title":"Reciprocal activity of AgRP and POMC neurons governs coordinated control of feeding and metabolism","volume":"6","author":"De Solis","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib29","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1242\/dmm.026609","article-title":"Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity","volume":"10","author":"Timper","year":"2017","journal-title":"Dis Model Mech"},{"key":"10.1016\/j.apsb.2026.06.035_bib30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/A:1008983615045","article-title":"Role of the melanocortin-4 receptor in metabolic rate and food intake in mice","volume":"9","author":"Chen","year":"2000","journal-title":"Transgenic Res"},{"key":"10.1016\/j.apsb.2026.06.035_bib31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.15252\/emmm.201404508","article-title":"Dual melanocortin-4 receptor and GLP-1 receptor agonism amplifies metabolic benefits in diet-induced obese mice","volume":"7","author":"Clemmensen","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib32","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1523\/JNEUROSCI.3282-12.2013","article-title":"Melanocortin-4 receptor regulates hippocampal synaptic plasticity through a protein kinase A-dependent mechanism","volume":"33","author":"Shen","year":"2013","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2026.06.035_bib33","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/j.1742-7843.2007.00133.x","article-title":"Functional evaluation of THIQ, a melanocortin 4 receptor agonist, in models of food intake and inflammation","volume":"101","author":"Muceniece","year":"2007","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.035_bib34","doi-asserted-by":"crossref","first-page":"S74","DOI":"10.1038\/sj.ijir.3900582","article-title":"Melanocortin receptor agonists, penile erection, and sexual motivation: human studies with Melanotan II","volume":"12","author":"Wessells","year":"2000","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.apsb.2026.06.035_bib35","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/db12-0598","article-title":"Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese Rhesus macaques","volume":"62","author":"Kievit","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.06.035_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa0803085","article-title":"Modulation of blood pressure by central melanocortinergic pathways","volume":"360","author":"Greenfield","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib37","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1161\/CIRCULATIONAHA.109.888529","article-title":"Cardiovascular side effects of antiobesity drugs","volume":"120","author":"Mark","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.035_bib38","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1126\/science.abf7958","article-title":"Structure reveals the activation mechanism of the MC4 receptor to initiate satiation signaling","volume":"372","author":"Israeli","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.035_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101401","article-title":"Neuroanatomical organization and functional roles of PVN MC4R pathways in physiological and behavioral regulations","volume":"55","author":"Singh","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.phrs.2018.01.004","article-title":"Understanding melanocortin-4 receptor control of neuronal circuits: toward novel therapeutics for obesity syndrome","volume":"129","author":"Ju","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.06.035_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2020.165835","article-title":"Signal pathway analysis of selected obesity-associated melanocortin-4 receptor class V mutants","volume":"1866","author":"Sharma","year":"2020","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2026.06.035_bib42","article-title":"MC4R in central and peripheral systems","volume":"7","author":"Wei","year":"2023","journal-title":"Adv Biol (Weinh)"},{"key":"10.1016\/j.apsb.2026.06.035_bib43","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165418","article-title":"A human obesity-associated MC4R mutation with defective Gq\/11\u03b1 signaling leads to hyperphagia in mice","volume":"134","author":"Metzger","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.035_bib44","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1172\/JCI76348","article-title":"Gq\/11\u03b1 and Gs\u03b1 mediate distinct physiological responses to central melanocortins","volume":"126","author":"Li","year":"2015","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.035_bib45","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1111\/febs.16176","article-title":"AgRP neurons: regulators of feeding, energy expenditure, and behavior","volume":"289","author":"Deem","year":"2022","journal-title":"FEBS J"},{"key":"10.1016\/j.apsb.2026.06.035_bib46","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0196-9781(03)00030-5","article-title":"Elongation studies of the human agouti-related protein (AGRP) core decapeptide (Yc[CRFFNAFC]Y) results in antagonism at the mouse melanocortin-3 receptor","volume":"24","author":"Joseph","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.apsb.2026.06.035_bib47","first-page":"164","article-title":"AgRP(83\u2013132) acts as an inverse agonist on the human-melanocortin-4 receptor","volume":"15","author":"Nijenhuis","year":"2001","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.035_bib48","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.1021\/acs.jmedchem.3c01822","article-title":"Novel cocrystal structures of peptide antagonists bound to the human melanocortin receptor 4 unveil unexplored grounds for structure-based drug design","volume":"67","author":"Gimenez","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.035_bib49","doi-asserted-by":"crossref","first-page":"7029","DOI":"10.1038\/s41467-024-50827-7","article-title":"Structure elucidation of a human melanocortin-4 receptor specific orthosteric nanobody agonist","volume":"15","author":"Fontaine","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.035_bib50","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41422-021-00552-3","article-title":"Structural insights into ligand recognition and activation of the melanocortin-4 receptor","volume":"31","author":"Zhang","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2026.06.035_bib51","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/s41422-021-00569-8","article-title":"Structures of active melanocortin-4 receptor-gs-protein complexes with NDP-alpha-MSH and setmelanotide","volume":"31","author":"Heyder","year":"2021","journal-title":"Cell Res"},{"key":"10.1016\/j.apsb.2026.06.035_bib52","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1126\/science.aaz8995","article-title":"Determination of the melanocortin-4 receptor structure identifies Ca2+ as a cofactor for ligand binding","volume":"368","author":"Yu","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.035_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.str.2025.03.004","article-title":"Structural basis for the constitutive activity of the melanocortin receptor family","volume":"33","author":"Feng","year":"2025","journal-title":"Structure"},{"key":"10.1016\/j.apsb.2026.06.035_bib54","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s40265-021-01470-9","article-title":"Setmelanotide: first approval","volume":"81","author":"Markham","year":"2021","journal-title":"Drugs"},{"key":"10.1016\/j.apsb.2026.06.035_bib55","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.035_bib56","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archinte.1950.00230100002001","article-title":"Effects of cortisone acetate and pituitary ACTH on rheumatoid arthritis, rheumatic fever and certain other conditions","volume":"85","author":"Hench","year":"1950","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib57","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF01457853","article-title":"Psychopharmacological and endocrinological effects of melanocyte stimulating hormones in normal man","volume":"55","author":"Ashton","year":"1977","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.apsb.2026.06.035_bib58","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1126\/science.1325670","article-title":"The cloning of a family of genes that encode the melanocortin receptors","volume":"257","author":"Mountjoy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.035_bib59","first-page":"1298","article-title":"Localization of the melanocortin-4 receptor (MC4-R) in neuroendocrine and autonomic control circuits in the brain","volume":"8","author":"Mountjoy","year":"1994","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.035_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/BF00995160","article-title":"Cloning, expression, and tissue distribution of a fifth melanocortin receptor subtype","volume":"20","author":"Fathi","year":"1995","journal-title":"Neurochem Res"},{"key":"10.1016\/j.apsb.2026.06.035_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/srep34938","article-title":"Effects of melanocortin 3 and 4 receptor deficiency on energy homeostasis in rats","volume":"6","author":"You","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.06.035_bib62","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.3390\/genes13122267","article-title":"Effect of the melanocortin 4-receptor Ile269Asn mutation on weight loss response to dietary, phentermine and bariatric surgery interventions","volume":"13","author":"Salazar-Valencia","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.apsb.2026.06.035_bib63","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI9238","article-title":"Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity","volume":"106","author":"Vaisse","year":"2000","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.035_bib64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.npep.2013.11.001","article-title":"The protective effects of the melanocortin receptor (MCR) agonist, melanotan-II (MTII), against binge-like ethanol drinking are facilitated by deletion of the MC3 receptor in mice","volume":"48","author":"Olney","year":"2014","journal-title":"Neuropeptides"},{"key":"10.1016\/j.apsb.2026.06.035_bib65","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/sj.bjp.0704437","article-title":"Activation of central melanocortin receptors by MT-II increases cavernosal pressure in rabbits by the neuronal release of NO","volume":"134","author":"Vemulapalli","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.035_bib66","doi-asserted-by":"crossref","first-page":"919","DOI":"10.3389\/fphar.2018.00919","article-title":"Ligand bias and its association with pro-resolving actions of melanocortin drugs","volume":"9","author":"Patruno","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.035_bib67","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.tips.2018.01.004","article-title":"MC4R agonists: structural overview on antiobesity therapeutics","volume":"39","author":"Gon\u00e7alves","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.06.035_bib68","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1111\/jcmm.17441","article-title":"MC4R biased signalling and the conformational basis of biological function selections","volume":"26","author":"Liu","year":"2022","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib69","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.mce.2010.07.007","article-title":"Alternative G protein coupling and biased agonism: new insights into melanocortin-4 receptor signalling","volume":"331","author":"Breit","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.035_bib70","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-076410","article-title":"Comparative effectiveness of GLP-1 receptor agonists on glycaemic control, body weight, and lipid profile for type 2 diabetes: systematic review and network meta-analysis","volume":"384","author":"Yao","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2026.06.035_bib71","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3390\/pharmaceutics17081036","article-title":"Emerging frontiers in GLP-1 therapeutics: a comprehensive evidence base","volume":"17","author":"Patel","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.apsb.2026.06.035_bib72","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.cmet.2018.05.008","article-title":"Patients with obesity caused by melanocortin-4 receptor mutations can be treated with a glucagon-like peptide-1 receptor agonist","volume":"28","author":"Iepsen","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib73","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1038\/s41591-025-03913-2","article-title":"Tirzepatide leads to weight reduction in people with obesity due to MC4R deficiency","volume":"31","author":"Bhatnagar","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156414","article-title":"A melanocortin 4- and glucagon-like peptide 1 receptor multiple agonist for the treatment of diabetes and obesity","volume":"174","author":"Ashlaw","year":"2026","journal-title":"Metabolism"},{"key":"10.1016\/j.apsb.2026.06.035_bib75","article-title":"GLP-1 receptor agonist treatment in morbid obesity and type 2 diabetes due to pathogenic homozygous melanocortin-4 receptor mutation: a case report","volume":"1","author":"Iepsen","year":"2020","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib76","doi-asserted-by":"crossref","DOI":"10.1172\/JCI177823","article-title":"Targeting melanocortin 4 receptor to treat sleep-disordered breathing in mice","volume":"135","author":"Amorim","year":"2025","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.035_bib77","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cmet.2024.02.010","article-title":"Age-related ciliopathy: obesogenic shortening of melanocortin-4 receptor-bearing neuronal primary cilia","volume":"36","author":"Oya","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib78","doi-asserted-by":"crossref","DOI":"10.1172\/JCI142064","article-title":"Melanocortin 4 receptor signals at the neuronal primary cilium to control food intake and body weight","volume":"131","author":"Wang","year":"2021","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.035_bib79","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1210\/jc.2009-2297","article-title":"Sympathetic function in human carriers of melanocortin-4 receptor gene mutations","volume":"95","author":"Sayk","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib80","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12670","article-title":"Late onset obesity in mice with targeted deletion of potassium inward rectifier Kir7.1 from cells expressing the melanocortin-4 receptor","volume":"31","author":"Anderson","year":"2019","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.apsb.2026.06.035_bib81","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14051","article-title":"G-protein-independent coupling of MC4R to Kir7.1 in hypothalamic neurons","volume":"520","author":"Ghamari-Langroudi","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.035_bib82","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.3390\/molecules24101892","article-title":"Current mechanistic and pharmacodynamic understanding of melanocortin-4 receptor activation","volume":"24","author":"Sharma","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2026.06.035_bib83","doi-asserted-by":"crossref","first-page":"7277","DOI":"10.1021\/bi0600300","article-title":"Pharmacological characterization of 40 human melanocortin-4 receptor polymorphisms with the endogenous proopiomelanocortin-derived agonists and the agouti-related protein (AGRP) antagonist","volume":"45","author":"Xiang","year":"2006","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2026.06.035_bib84","doi-asserted-by":"crossref","first-page":"E436","DOI":"10.1152\/ajpendo.00439.2021","article-title":"Stimulation of Gs signaling in MC4R cells by DREADD increases energy expenditure, suppresses food intake, and increases locomotor activity in mice","volume":"322","author":"Matsumura","year":"2022","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib85","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000054686","article-title":"Expression of functional melanocortin-4 receptor in the hypothalamic GT1-1 cell line","volume":"74","author":"Khong","year":"2001","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.apsb.2026.06.035_bib86","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/978-981-13-1286-1_3","article-title":"Neuronal cAMP\/PKA signaling and energy homeostasis","volume":"1090","author":"Yang","year":"2018","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.apsb.2026.06.035_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111579","article-title":"Melanocortin-4 receptors activate sympathetic preganglionic neurons and elevate blood pressure via TRPV1","volume":"41","author":"Ju","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.06.035_bib88","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cell.2012.12.022","article-title":"Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons","volume":"152","author":"Sohn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.035_bib89","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1161\/CIRCRESAHA.125.326394","article-title":"Melanocortin system activates carotid body arterial chemoreceptors in hypertension","volume":"137","author":"Pauza","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.035_bib90","doi-asserted-by":"crossref","first-page":"4256","DOI":"10.1210\/en.2012-1113","article-title":"Gs\u03b1 deficiency in the paraventricular nucleus of the hypothalamus partially contributes to obesity associated with Gs\u03b1 mutations","volume":"153","author":"Chen","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2026.06.035_bib91","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.jss.2006.02.003","article-title":"Activation of the melanocortin-4 receptor mobilizes intracellular free calcium in immortalized hypothalamic neurons","volume":"132","author":"Newman","year":"2006","journal-title":"J Surg Res"},{"key":"10.1016\/j.apsb.2026.06.035_bib92","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors","volume":"25","author":"Ballesteros","year":"1995","journal-title":"Methods Neurosci"},{"key":"10.1016\/j.apsb.2026.06.035_bib93","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s40267-022-00929-3","article-title":"Setmelanotide in obesity: a profile of its use","volume":"38","author":"Kang","year":"2022","journal-title":"Drugs Ther Perspect"},{"key":"10.1016\/j.apsb.2026.06.035_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2022.120857","article-title":"Structural analysis of setmelanotide binding to MC4R variants in comparison to wild-type receptor","volume":"307","author":"Hammad","year":"2022","journal-title":"Life Sci"},{"key":"10.1016\/j.apsb.2026.06.035_bib95","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1021\/acs.jmedchem.9b00860","volume":"63","author":"Koerperich","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.035_bib96","doi-asserted-by":"crossref","first-page":"15520","DOI":"10.1021\/bi0117192","article-title":"High-resolution NMR structure of the chemically-synthesized melanocortin receptor binding domain AGRP (87\u2013132) of the agouti-related protein","volume":"40","author":"McNulty","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.apsb.2026.06.035_bib97","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/B978-0-12-417197-8.00005-5","article-title":"Constitutive activity in melanocortin-4 receptor: biased signaling of inverse agonists","volume":"70","author":"Tao","year":"2014","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.035_bib98","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0196-9781(03)00104-9","article-title":"Inverse agonist activity of agouti and agouti-related protein","volume":"24","author":"Chai","year":"2003","journal-title":"Peptides"},{"key":"10.1016\/j.apsb.2026.06.035_bib99","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0165-6147(03)00130-5","article-title":"Inverse agonism gains weight","volume":"24","author":"Adan","year":"2003","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.apsb.2026.06.035_bib100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0167-0115(01)00234-8","article-title":"Agouti-related protein functions as an inverse agonist at a constitutively active brain melanocortin-4 receptor","volume":"99","author":"Haskell-Luevano","year":"2001","journal-title":"Regul Pept"},{"key":"10.1016\/j.apsb.2026.06.035_bib101","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.108862","article-title":"Human MC4R variants affect endocytosis, trafficking and dimerization revealing multiple cellular mechanisms involved in weight regulation","volume":"34","author":"Brouwers","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.06.035_bib102","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2337\/db25-98-OR","article-title":"98-OR: Melanocortin 4 receptor-mediated effects require beta-arrestin 2 signaling","volume":"74","author":"Rashid","year":"2025","journal-title":"Diabetes"},{"key":"10.1016\/j.apsb.2026.06.035_bib103","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3003025","article-title":"Tonic ubiquitination of the central body weight regulator melanocortin receptor 4 (MC4R) promotes its constitutive exit from cilia","volume":"23","author":"Ojeda-Naharros","year":"2025","journal-title":"PLoS Biol"},{"key":"10.1016\/j.apsb.2026.06.035_bib104","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/978-1-0716-3818-7_14","article-title":"Automated patch clamp recordings of GPCR-gated ion channels: targeting the MC4-R\/Kir7.1 potassium channel complex","volume":"2796","author":"Hernandez","year":"2024","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2026.06.035_bib105","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-1-4939-7362-0_16","article-title":"Characterization of MC4R regulation of the Kir7.1 channel using the Tl+ flux assay","volume":"1684","author":"Litt","year":"2018","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.apsb.2026.06.035_bib106","doi-asserted-by":"crossref","first-page":"C694","DOI":"10.1152\/ajpcell.00335.2022","article-title":"The unique structural characteristics of the Kir 7.1 inward rectifier potassium channel: a novel player in energy homeostasis control","volume":"324","author":"Hernandez","year":"2023","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.apsb.2026.06.035_bib107","article-title":"Structure of the ion channel Kir7.1 and implications for its function in normal and pathophysiologic states","author":"Peisley","year":"2024","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2026.06.035_bib108","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2403891122","article-title":"Hypothalamic opsin 3 suppresses MC4R signaling and potentiates Kir7.1 to promote food consumption","volume":"122","author":"Haddad","year":"2025","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.06.035_bib109","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1210\/clinem\/dgae210","article-title":"MC4R variants modulate \u03b1-MSH and setmelanotide induced cellular signaling at multiple levels","volume":"109","author":"Rodr\u00edguez Rond\u00f3n","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib110","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.regpep.2006.04.010","article-title":"Molecular basis of melanocortin-4 receptor for AGRP inverse agonism","volume":"136","author":"Chen","year":"2006","journal-title":"Regul Pept"},{"key":"10.1016\/j.apsb.2026.06.035_bib111","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/s41421-023-00586-4","article-title":"Structural insights into ligand recognition and subtype selectivity of the human melanocortin-3 and melanocortin-5 receptors","volume":"9","author":"Feng","year":"2023","journal-title":"Cell Discov"},{"key":"10.1016\/j.apsb.2026.06.035_bib112","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/s41594-021-00645-y","article-title":"Molecular basis for kinin selectivity and activation of the human bradykinin receptors","volume":"28","author":"Yin","year":"2021","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.apsb.2026.06.035_bib113","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41586-018-0219-7","article-title":"Structure of the \u03bc-opioid receptor-Gi protein complex","volume":"558","author":"Koehl","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.035_bib114","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41586-025-09643-2","article-title":"Designing allosteric modulators to change GPCR G protein subtype selectivity","volume":"648","author":"Moore","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.035_bib115","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1038\/s41586-023-06169-3","article-title":"Class B1 GPCR activation by an intracellular agonist","volume":"618","author":"Kobayashi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.035_bib116","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41586-023-06395-9","article-title":"GPCR activation and GRK2 assembly by a biased intracellular agonist","volume":"620","author":"Duan","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.035_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.04.053","article-title":"\u03b2-Arrestin-biased allosteric modulator of NTSR1 selectively attenuates addictive behaviors","volume":"181","author":"Slosky","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.035_bib118","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41591-018-0015-9","article-title":"MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency","volume":"24","author":"Clement","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib119","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1016\/j.bbadis.2017.03.020","article-title":"Bench-top to clinical therapies: a review of melanocortin ligands from 1954 to 2016","volume":"1863","author":"Ericson","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2026.06.035_bib120","doi-asserted-by":"crossref","first-page":"16853","DOI":"10.1074\/jbc.274.24.16853","article-title":"Conformation of the core sequence in melanocortin peptides directs selectivity for the melanocortin MC3 and MC4 receptors","volume":"274","author":"Oosterom","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.06.035_bib121","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/PL00000868","article-title":"Melanocortin receptors: their functions and regulation by physiological agonists and antagonists","volume":"58","author":"Abdel-Malek","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2026.06.035_bib122","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jbspin.2012.09.009","article-title":"ACTH as first line treatment for acute gout in 181 hospitalized patients","volume":"80","author":"Daoussis","year":"2013","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.apsb.2026.06.035_bib123","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/jid.2015.16","article-title":"An \u03b1-MSH analog in erythropoietic protoporphyria","volume":"135","author":"Luger","year":"2015","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.apsb.2026.06.035_bib124","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/17512433.2021.1879638","article-title":"Afamelanotide for prevention of phototoxicity in erythropoietic protoporphyria","volume":"14","author":"Wensink","year":"2021","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.035_bib125","doi-asserted-by":"crossref","first-page":"75","DOI":"10.3390\/neurolint14010006","article-title":"Bremelanotide for treatment of female hypoactive sexual desire","volume":"14","author":"Edinoff","year":"2022","journal-title":"Neurol Int"},{"key":"10.1016\/j.apsb.2026.06.035_bib126","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1097\/AOG.0000000000003500","article-title":"Bremelanotide for the treatment of hypoactive sexual desire disorder: two randomized phase 3 trials","volume":"134","author":"Kingsberg","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.apsb.2026.06.035_bib127","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/clpt.2009.167","article-title":"Potent and selective agonism of the melanocortin receptor 4 with MK-0493 does not induce weight loss in obese human subjects: energy intake predicts lack of weight loss efficacy","volume":"86","author":"Krishna","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.035_bib128","unstructured":"ClinicalTrials.gov. An open-label extension study of bivamelagon in participants with acquired hypothalamic obesity. Identifier, NCT07156578. Available from: https:\/\/clinicaltrials.gov\/study\/NCT07156578."},{"key":"10.1016\/j.apsb.2026.06.035_bib129","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1002\/jcph.211","article-title":"Investigation of safety, tolerability, pharmacokinetics, and pharmacodynamics of single and multiple doses of a long-acting \u03b1-MSH analog in healthy overweight and obese subjects","volume":"54","author":"Royalty","year":"2014","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.035_bib130","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/oby.20678","article-title":"Effects of a novel MC4R agonist on maintenance of reduced body weight in diet-induced obese mice","volume":"22","author":"Skowronski","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/j.apsb.2026.06.035_bib131","unstructured":"ClinicalTrials.gov. A phase 1 study of RM-718 in participants with obesity or MC4R pathway diseases. Identifier, NCT06239116. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06239116."},{"key":"10.1016\/j.apsb.2026.06.035_bib132","doi-asserted-by":"crossref","first-page":"3195","DOI":"10.1021\/acs.jmedchem.2c02012","article-title":"Discovery of the potent and selective MC4R antagonist PF-07258669 for the potential treatment of appetite loss","volume":"66","author":"Garnsey","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.035_bib133","article-title":"Melanocortin-4 receptor antagonist TCMCB07 alleviates chemotherapy-induced anorexia and weight loss in rats","volume":"135","author":"Zhu","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.035_bib134","doi-asserted-by":"crossref","first-page":"2555","DOI":"10.1021\/jm00132a010","article-title":"Potent and prolonged acting cyclic lactam analogues of \u03b1-melanotropin: design based on molecular dynamics","volume":"32","author":"Al-Obeidi","year":"1989","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.035_bib135","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12974-018-1140-6","article-title":"Activation of melanocortin receptor 4 with RO27-3225 attenuates neuroinflammation through AMPK\/JNK\/p38 MAPK pathway after intracerebral hemorrhage in mice","volume":"15","author":"Chen","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.apsb.2026.06.035_bib136","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1021\/jm9017866","article-title":"Discovery of a selective small-molecule melanocortin-4 receptor agonist with efficacy in a pilot study of sexual dysfunction in humans","volume":"53","author":"Lansdell","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.035_bib137","doi-asserted-by":"crossref","first-page":"4589","DOI":"10.1021\/jm025539h","article-title":"Design and pharmacology of N-[(3R)-1,2,3,4-tetrahydroisoquinolinium-3-ylcarbonyl]-(1R)-1-(4-chlorobenzyl)-2-[4-cyclohexyl-4-(1H-1,2,4-triazol-1-ylmethyl)piperidin-1-yl]-2-oxoethylamine (1), a potent, selective, melanocortin subtype-4 receptor agonist","volume":"45","author":"Sebhat","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.035_bib138","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1021\/jm00018a005","article-title":"Cyclic lactam alpha-melanotropin analogues of Ac-Nle4-cyclo[Asp5, D-Phe7, Lys10] \u03b1-melanocyte-stimulating hormone-(4\u201310)-NH2 with bulky aromatic amino acids at position 7 show high antagonist potency and selectivity at specific melanocortin receptors","volume":"38","author":"Hruby","year":"1995","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.035_bib139","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1006\/bbrc.2002.6739","article-title":"Design and synthesis of highly potent and selective melanotropin analogues of SHU9119 modified at position 6","volume":"292","author":"Grieco","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2026.06.035_bib140","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1016\/j.bmcl.2007.06.010","article-title":"Identification of a novel series of benzimidazoles as potent and selective antagonists of the human melanocortin-4 receptor","volume":"17","author":"Poitout","year":"2007","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2026.06.035_bib141","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1021\/acschemneuro.7b00495","article-title":"Structure-activity relationship studies of a macrocyclic AGRP-mimetic scaffold c[Pro-Arg-Phe-Phe-Asn-Ala-Phe-DPro] yield potent and selective melanocortin-4 receptor antagonists and melanocortin-5 receptor inverse agonists that increase food intake in mice","volume":"9","author":"Fleming","year":"2018","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.apsb.2026.06.035_bib142","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1007\/s11064-021-03453-4","article-title":"Neuropeptide \u03b1-melanocyte-stimulating hormone promotes neurological recovery and repairs cerebral ischemia\/reperfusion injury in type 1 diabetes","volume":"47","author":"Goit","year":"2022","journal-title":"Neurochem Res"},{"key":"10.1016\/j.apsb.2026.06.035_bib143","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/bjd.13598","article-title":"Long-term observational study of afamelanotide in 115 patients with erythropoietic protoporphyria","volume":"172","author":"Biolcati","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.apsb.2026.06.035_bib144","doi-asserted-by":"crossref","first-page":"5754","DOI":"10.1073\/pnas.77.10.5754","article-title":"4-Norleucine, 7-D-phenylalanine-\u03b1-melanocyte-stimulating hormone: a highly potent \u03b1-melanotropin with ultralong biological activity","volume":"77","author":"Sawyer","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.06.035_bib145","doi-asserted-by":"crossref","first-page":"4998","DOI":"10.1021\/jm000211e","article-title":"D-Amino acid scan of \u03b3-melanocyte-stimulating hormone: importance of Trp(8) on human MC3 receptor selectivity","volume":"43","author":"Grieco","year":"2000","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.035_bib146","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/385165a0","article-title":"Role of melanocortinergic neurons in feeding and the agouti obesity syndrome","volume":"385","author":"Fan","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.035_bib147","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ejphar.2010.10.101","article-title":"Implication of the melanocortin-3 receptor in the regulation of food intake","volume":"660","author":"Irani","year":"2011","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.035_bib148","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/sj.mp.4000854","article-title":"Association between an agouti-related protein gene polymorphism and anorexia nervosa","volume":"6","author":"Vink","year":"2001","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.apsb.2026.06.035_bib149","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.jmb.2004.12.030","article-title":"Structures of the agouti signaling protein","volume":"346","author":"McNulty","year":"2005","journal-title":"J Mol Biol"},{"key":"10.1016\/j.apsb.2026.06.035_bib150","doi-asserted-by":"crossref","first-page":"499","DOI":"10.2147\/CEOR.S410082","article-title":"Acthar Gel (RCI): a narrative literature review of clinical and economic evidence","volume":"15","author":"Wan","year":"2023","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/j.apsb.2026.06.035_bib151","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1056\/NEJMoa1411481","article-title":"Afamelanotide for erythropoietic protoporphyria","volume":"373","author":"Langendonk","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib152","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1038\/s41388-018-0216-1","article-title":"cAMP-independent non-pigmentary actions of variant melanocortin 1 receptor: AKT-mediated activation of protective responses to oxidative DNA damage","volume":"37","author":"Castej\u00f3n-Gri\u00f1\u00e1n","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.apsb.2026.06.035_bib153","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature23887","article-title":"Palmitoylation-dependent activation of MC1R prevents melanomagenesis","volume":"549","author":"Chen","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.035_bib154","doi-asserted-by":"crossref","first-page":"3674","DOI":"10.1021\/acs.jmedchem.8b00170","article-title":"Development of novel melanocortin receptor agonists based on the cyclic peptide framework of sunflower trypsin inhibitor-1","volume":"61","author":"Durek","year":"2018","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.035_bib155","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa1512693","article-title":"Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist","volume":"375","author":"K\u00fchnen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib156","doi-asserted-by":"crossref","first-page":"5728","DOI":"10.3390\/ijms21165728","article-title":"Structural complexity and plasticity of signaling regulation at the melanocortin-4 receptor","volume":"21","author":"Kleinau","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.035_bib157","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1159\/000516282","article-title":"A melanocortin-4 receptor agonist induces skin and hair pigmentation in patients with monogenic mutations in the leptin-melanocortin pathway","volume":"34","author":"Kanti","year":"2021","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.apsb.2026.06.035_bib158","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.regpep.2009.03.006","article-title":"Key amino acid residues in the melanocortin-4 receptor for nonpeptide THIQ specific binding and signaling","volume":"155","author":"Yang","year":"2009","journal-title":"Regul Pept"},{"key":"10.1016\/j.apsb.2026.06.035_bib159","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0014-2999(02)02479-2","article-title":"Activation of melanocortin MC4 receptors increases erectile activity in rats ex copula","volume":"454","author":"Martin","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.035_bib160","doi-asserted-by":"crossref","first-page":"11381","DOI":"10.1073\/pnas.172378699","article-title":"A role for the melanocortin 4 receptor in sexual function","volume":"99","author":"Van der Ploeg","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.06.035_bib161","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/j.peptides.2005.01.023","article-title":"Discovery that a melanocortin regulates sexual functions in male and female humans","volume":"26","author":"Hadley","year":"2005","journal-title":"Peptides"},{"key":"10.1016\/j.apsb.2026.06.035_bib162","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1210\/er.2009-0037","article-title":"The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology","volume":"31","author":"Tao","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/j.apsb.2026.06.035_bib163","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.bbadis.2013.06.006","article-title":"Activation of MAPK by inverse agonists in six naturally occurring constitutively active mutant human melanocortin-4 receptors","volume":"1832","author":"Mo","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.apsb.2026.06.035_bib164","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1016\/j.bbadis.2017.03.001","article-title":"Pharmacological chaperones for the misfolded melanocortin-4 receptor associated with human obesity","volume":"1863","author":"Huang","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2026.06.035_bib165","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1016\/j.bmcl.2011.02.090","article-title":"Discovery of a piperazine urea based compound as a potent, selective, orally bioavailable melanocortin subtype-4 receptor partial agonist","volume":"21","author":"Hong","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.apsb.2026.06.035_bib166","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/s12881-018-0654-1","article-title":"Heterozygous versus homozygous phenotype caused by the same MC4R mutation: novel mutation affecting a large consanguineous kindred","volume":"19","author":"Drabkin","year":"2018","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.apsb.2026.06.035_bib167","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1152\/physrev.00024.2017","article-title":"POMC: the physiological power of hormone processing","volume":"98","author":"Harno","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/j.apsb.2026.06.035_bib168","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1016\/j.cell.2024.06.003","article-title":"Transforming obesity: the advancement of multi-receptor drugs","volume":"187","author":"Kusminski","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.035_bib169","doi-asserted-by":"crossref","first-page":"4473","DOI":"10.1172\/JCI75276","article-title":"The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss","volume":"124","author":"Secher","year":"2014","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.035_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.physbeh.2020.112870","article-title":"Hindbrain melanocortin 3\/4 receptors modulate the food intake and body weight suppressive effects of the GLP-1 receptor agonist, liraglutide","volume":"220","author":"Fortin","year":"2020","journal-title":"Physiol Behav"},{"key":"10.1016\/j.apsb.2026.06.035_bib171","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.cmet.2014.10.004","article-title":"The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo","volume":"20","author":"Panaro","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib172","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2021.04.014","article-title":"A gut-intrinsic melanocortin signaling complex augments L-cell secretion in humans","volume":"161","author":"Sun","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2026.06.035_bib173","unstructured":"A Phase 2 study evaluating the co-administration of bremelanotide with tirzepatide for the treatment of obesity (BMT-801). Identifier: NCT06565611. Available from: https:\/\/clinicaltrials.gov\/study\/NCT06565611."},{"key":"10.1016\/j.apsb.2026.06.035_bib174","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2018-00258","article-title":"Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at MC4R agonist treatment","volume":"103","author":"Ayers","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib175","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1038\/s41591-022-02106-5","article-title":"Human loss-of-function variants in the serotonin 2C receptor associated with obesity and maladaptive behavior","volume":"28","author":"He","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.06.035_bib176","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cmet.2011.01.014","article-title":"Autonomic MC sets the metabolic tone","volume":"13","author":"Yi","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.06.035_bib177","first-page":"1","article-title":"The role of PVN MC4R neural pathway in autonomic control of metabolic homeostasis and cardiovascular function","volume":"34","author":"Singh","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.06.035_bib178","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1172\/JCI121653","article-title":"Melanocortin 4 receptors switch reward to aversion","volume":"128","author":"DiFeliceantonio","year":"2018","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.035_bib179","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.psyneuen.2014.01.010","article-title":"Loss of melanocortin-4 receptor function attenuates HPA responses to psychological stress","volume":"42","author":"Ryan","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.apsb.2026.06.035_bib180","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1307889","article-title":"Could setmelanotide be the game-changer for acquired hypothalamic obesity?.","volume":"14","author":"van Santen","year":"2024","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.035_bib181","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(22)00277-7","article-title":"Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstr\u00f6m syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period","volume":"10","author":"Haqq","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.035_bib182","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1172\/JCI138392","article-title":"Melanocortin-4 receptor antagonist TCMCB07 ameliorates cancer- and chronic kidney disease\u2013associated cachexia","volume":"130","author":"Zhu","year":"2020","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.035_bib183","first-page":"19","article-title":"The complicated clinical course in a case of atypical lipodystrophy after development of neutralizing antibody to metreleptin: treatment with setmelanotide","volume":"2020","author":"Akinci","year":"2020","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/j.apsb.2026.06.035_bib184","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11906-019-0951-x","article-title":"Melanocortin-4 receptors and sympathetic nervous system activation in hypertension","volume":"21","author":"da Silva","year":"2019","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/j.apsb.2026.06.035_bib185","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3390\/biom12081119","article-title":"A setmelanotide-like effect at MC4R is achieved by MC4R dimer separation","volume":"12","author":"Reininghaus","year":"2022","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2026.06.035_bib186","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000334903","article-title":"MC4R dimerization in the paraventricular nucleus and GHSR\/MC3R heterodimerization in the arcuate nucleus: is there relevance for body weight regulation?.","volume":"95","author":"Rediger","year":"2012","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.apsb.2026.06.035_bib187","doi-asserted-by":"crossref","first-page":"8324","DOI":"10.1038\/s41467-025-63988-w","article-title":"MRAP2 modifies the signaling and oligomerization state of the melanocortin-4 receptor","volume":"16","author":"Sohail","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.035_bib188","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.155900","article-title":"MRAP2 regulates energy homeostasis by promoting primary cilia localization of MC4R","volume":"8","author":"Bernard","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2026.06.035_bib189","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/biom11030481","article-title":"MRAP2 interaction with melanocortin-4 receptor in snakeHead (Channa argus)","volume":"11","author":"Wen","year":"2021","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2026.06.035_bib190","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygcen.2019.113234","article-title":"Orange-spotted grouper melanocortin-4 receptor: modulation of signaling by MRAP2","volume":"284","author":"Rao","year":"2019","journal-title":"Gen Comp Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.035_bib191","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.bbadis.2017.05.008","article-title":"Melanocortin receptor accessory proteins (MRAPs): functions in the melanocortin system and beyond","volume":"1863","author":"Rouault","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"10.1016\/j.apsb.2026.06.035_bib192","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0140320","article-title":"hMRAP\u03b1, but not hMRAP2, enhances hMC4R constitutive activity in HEK293 cells and this is not dependent on hMRAP\u03b1 induced changes in hMC4R complex N-linked glycosylation","volume":"10","author":"Kay","year":"2015","journal-title":"PLoS One"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526003928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526003928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:00:21Z","timestamp":1786046421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526003928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":192,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2211383526003928"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.06.035","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rationale of renewed efforts in developing MC4R modulators to treat metabolic disorders","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.06.035","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}